147 related articles for article (PubMed ID: 12140514)
1. Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy.
Nghiem HV; Francis IR; Fontana R; Hussain H; Platt JF; Higgins E; Bree RL
Curr Probl Diagn Radiol; 2002; 31(3):105-11. PubMed ID: 12140514
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
Lim HK; Choi D; Lee WJ; Kim SH; Lee SJ; Jang HJ; Lee JH; Lim JH; Choo IW
Radiology; 2001 Nov; 221(2):447-54. PubMed ID: 11687689
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors.
Berber E; Siperstein A
Ann Surg Oncol; 2008 Oct; 15(10):2757-64. PubMed ID: 18618182
[TBL] [Abstract][Full Text] [Related]
4. [Flexible applicator systems for radiofrequency ablation (RFA) of hepatic tumors].
Gebauer B; Gaffke G; Hünerbein M; Felix R; Stroszczynski C
Rofo; 2003 Dec; 175(12):1720-3. PubMed ID: 14661145
[TBL] [Abstract][Full Text] [Related]
5. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
6. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
7. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience.
Marquez HP; Puippe G; Mathew RP; Alkadhi H; Pfammatter T; Fischer MA
Cardiovasc Intervent Radiol; 2017 Jan; 40(1):90-98. PubMed ID: 27812781
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
10. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.
Morimoto M; Sugimori K; Shirato K; Kokawa A; Tomita N; Saito T; Tanaka N; Nozawa A; Hara M; Sekihara H; Shimada H; Imada T; Tanaka K
Hepatology; 2002 Jun; 35(6):1467-75. PubMed ID: 12029632
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma.
Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K
Cancer; 2001 Apr; 91(7):1342-8. PubMed ID: 11283935
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment.
Tsuda M; Majima K; Yamada T; Saitou H; Ishibashi T; Takahashi S
Clin Imaging; 2001; 25(6):409-15. PubMed ID: 11733155
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography-guided percutaneous microwave ablation with artificial ascites for problematic hepatocellular tumors.
Wang Y; Zhang L; Li Y; Wang W
Int J Hyperthermia; 2020; 37(1):256-262. PubMed ID: 32157926
[No Abstract] [Full Text] [Related]
16. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns.
Catalano O; Lobianco R; Esposito M; Siani A
Abdom Imaging; 2001; 26(4):375-83. PubMed ID: 11441549
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis.
Xie L; Cao F; Qi H; Song Z; Shen L; Chen S; Hu Y; Chen C; Fan W
Int J Hyperthermia; 2019; 36(1):1122-1128. PubMed ID: 31739695
[No Abstract] [Full Text] [Related]
20. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
Minami Y; Kitai S; Kudo M
Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
